The antibody (Ab) response to human adenovirus (AV) early antigens (EA) in acute AV infections was studied by the immunoperoxidase antibody technique for determining virus-specific immunoglobulin G (IPA-IgG). AV-EA-Ab appeared about 5 days after the onset of clinical symptoms, reached a peak 15 to 30 days later, and declined in titer after a few months. The staining pattern in the IPAIgG reaction was usually nuclear; however, in most primary infections sera obtained 2 to 3 weeks after the onset of infection also showed cytoplasmic staining. According to the recent deoxyribonucleic acid homology classification of human AV in five groups (A, B, C, D, and E), the EA-Ab response in primary human infections was found to be group specific for groups A to D, with consistent crossreactions with group E. In AV type 4 (group E) infections, EA-Ab appeared to be directed against all groups, although at different titers. Comparable results were obtained using AV type-specific animal antisera. Thus, it was concluded that group E shares EA with all the other groups. Furthermore, in each individual with remote AV infections, the current infection elicited an anamnestic EA-Ab response to all AV groups responsible for previous infections. In diagnostic virology these findings can be applied to the rapid diagnosis of a current (or recent) AV infection on a single serum sample and to the rapid group identification of clinical isolates by using type-specific animal antisera containing EA-Ab (one for each group) or sera from patients with primary AV infections.
Antibody (Ab) to early antigens (EA) of some human deoxyribonucleic acid (DNA) viruses, such as cytomegalovirus (3, 21) and varicellazoster virus (4) , has been shown to be a marker of a current (primary or reactivated) infection. The Ab response to EA (referred to as T antigens) of human adenoviruses (AV) has mostly been studied in tumor and acutely infected cells by complement fixation (CF) and immunofluorescent-antibody (IFA) tests with sera of tumor-bearing hamsters (7, 11, 14, 15) . Homotypic EA-Ab response was demonstrated in human acute AV infections; however, heterotypic reactions were not investigated (13) .
In the present report, the EA-Ab response to human AV of different groups has been demonstrated in patients with acute AV infection, using the immunoperoxidase technique for determining virus-specific immunoglobulin G (IPA-IgG) . The results show that EA induced by AV type 4 (group E) cross-reacted with EA of all other groups, whereas EA of AV groups A to D did not show intergroup cross-reactions other than with type 4. Intragroup cross-reactivity among serotypes was consistent (i.e., AV types of the same group could not be distinguished by EA reactivity). Furthermore, a new AV infection elicited, as a rule, an anamnestic EA-Ab response to all AV groups responsible for previous infections in the same individual. These observations confirm the recent classification of human AV in five groups (A to E), based upon DNA homologies (6) and electrophoresis of structural polypeptides (23) , and also offer practical applications in diagnostic virology.
MATERIALS AND METHODS
Cell cultures. HEp-2 cell cultures obtained from the American Type Culture Collection (ATCC, Rock- ville, Md.) were used in passages 380 to 390 for virus propagation, preparation of complement-fixing (CF) and hemagglutinating (HA) antigens and cell-free virus stocks. Human embryonic lung fibroblast (HELF) cells at passage 20 to 25 were used for neutralization and IPA-IgG tests and for preparation of cell substrates for AV EA-Ab determination. Eagle minimum essential medium (EMEM) with 10% fetal calf serum (FCS) was used as the growth medium, and EMEM with 2% FCS was used as the maintenance medium. All cell cultures employed were repeatedly tested by cultural and cytochemical methods and were found to be mycoplasma free.
Virus strains. AV type 1 to 31 seed viruses and rabbit antisera were originally obtained from ATCC. Viruses were subcultured three to five times on HEp-2 cells before preparing cell-free stocks and CF and HA antigens. Stock virus of most AV serotypes was prepared by infecting HEp-2 monolayers at a multi-plicity of infection of 1 to 10 50% tissue culture infective doses per cell. After 3 h of adsorption at 37°C, the maintenance medium was added, and incubation continued until the monolayers were completely detached. Infected cells were then harvested and sonicated; cell-free and cell-associated viruses were pooled and stored in aliquots at -80°C.
Preparation of cultures containing AV-EA and AV-LA. Confluent HELF monolayers were prepared in tissue culture microplates (Falcon Plastics, Oxnard, Calif.); each well was inoculated with 300 to 1,000 infectious units (as determined by the immunoperoxidase-stained cell assay [IPSCA] ; see below) of a single AV serotype in 0.050 ml. After 3 h of incubation at 37°C in a 5% C02-air-humidified atmosphere, the cells were washed three times with Hanks balanced salt solution (HBSS). Cultures for EA were then refed with maintenance medium containing 40 ,ug of cytosine arabinoside (Ara-C) per ml and incubated for 24 h. After fixation with absolute ethanol, microplates were either stained immediately or stored at -80°C. The absence of mature AV particles in infected cultures treated with Ara-C was confirmed by the lack of staining using a reference serum positive for Ab to AV-late antigens (LA), but not to EA. Cultures for LA were prepared similarly; however, after virus adsorption, they were refed with Ara-C-free medium and incubated for 48 to 96 h, depending on the AV serotype (see below).
Determination of AV-EA and AV-LA IgG Ab by IPA. The application of test serum dilutions and peroxidase-conjugated goat anti-human IgG (gamma chain-specific) IgG fraction (Cappel Laboratories, Cochranville, Pa.) onto HELF microcultures containing AV-EA was performed as previously reported for human cytomegalovirus (3) and varicella-zoster virus (4) EA-Ab determination. An identical staining procedure was followed for determining LA-Ab in human sera. When reference rabbit antisera were tested, a peroxidase-conjugated IgG fraction of sheep anti-rabbit IgG (Cappel Laboratories) was way, it was shown that at 24 h p.i. more than 95% AV-infected cells were EA positive, while at 48 h p.i. less than 5% of the AV-infected cells contained EA (Fig. 3) . Similar experiments were performed on microcultures refed, after virus adsorption, with medium containing Ara-C. In Ara-C-treated cultures only EA were detected at 24 and 36 h p.i., whereas at 48 h p.i. LA were observed in a small proportion (<5%) of AVinfected cells. Therefore, it was decided to prepare EA cell substrates by fixing Ara-C-treated, AV-infected cultures at 24 h p.i. The same procedure was later used for optimal preparation of EA cultures infected with all other AV serotypes. Positive IPA-IgG reaction for AV-EA was revealed by the appearance of nuclear staining in the absence of nuclear inclusions. The morphological staining patterns of EA induced by AV serotypes of different groups did not differ appreciably (Fig. 4) .
Degree of specificity of AV-EA-Ab response. The specificity of EA-Ab response to AV of different groups was investigated by using type-specific rabbit antisera and convalescentphase sera from infants with primary AV infections. The EA-Ab response by IPA-IgG in typespecific antisera identified five AV groups identical to those distinguished by Green et al. in their DNA homology studies (6) . This classification, which will be referred to from now on, were also confirmed by the presence of EA-Ab responses similar to those observed in reference animal antisera. In convalescent sera, HI or neutralizing Ab or both were consistently associated with an EA-Ab response to the AV group of the type isolated (Table 2 ). In addition, individuals with AV infection by serotypes of groups A (AV type 12), B (AV type 7), C (AV types 1 and 2), and D (AV type 8) also responded to EA induced by AV type 4 (group E), whereas a patient with primary type 4 infection showed serological response, at different titers, to EA of all AV groups. In primary AV infections, the EA-Ab response did not appear before 4 days after the onset of clinical symptoms (cases R-7, 1878, 1032, and 1141b), but was already evident after 7 days (case 1544). In most EA-Ab-positive sera from patients with primary infection, cytoplasmic staining was associated, at a lower titer, with the usual EA nuclear staining pattern. However, in each of these patients, cytoplasmic staining was only homotypic, appearing 2 to 3 weeks and lasting 2 to 3 months after the onset of symptoms.
EA-Ab response in humans with previous AV infections. In patients with a current acute infection, diagnosis of a past AV infection was established by detection in the acute-phase serum of CF or IPA LA-Ab or both and of HI or neutralizing Ab to one or more AV serotypes or both. Examples of EA-Ab response in patients with actual acute and remote (single or multiple) AV infections are presented in Table 3 . The EAAb response to the AV group of the actually infecting serotype substantially followed the patterns observed in primary infections, but was consistently associated with a simultaneous response to all the groups responsible for previous infections in the same patient (anamnestic response). The development of EA-Ab response was also comparable to that observed in primary infections: the peak titer was reached in 1 to 2 months, and then it declined gradually after the third month (Fig. 5) . A new rise in EA-Ab titer was observed when a subsequent AV infection occurred. The EA-Ab titers in convalescentphase sera from 23 other patients with a current acute and with remote AV infections are reported in Table 4 . In all cases, the anamnestic response to the groups causing previous infections was diagnosis of primary infection was established appeared impaired (Table 5) . Two patients (Rby AV isolation and detection of a fourfold or 3 and R-19) responded normally, although at greater rise in family-specific and/or type-spe-low titers. In one case (R-12) the EA-Ab recific Ab titer between acute and convalescent-sponse to the group responsible for actual infecphase serum; diagnosis of remote infection was tion was not detected; in two cases (R-17 and Rbased upon persistence of HI and/or neutralizing 2), the anamnestic response was lacking to one, Ab in acute and convalescent-phase sera drawn but not to another, AV group; in another patient at a 3-to 4-week interval. In these patients the (1870) sponse is directed to the AV groups of the serotypes responsible for current and previous infections in the same patients (anamnestic response). Thus, the presence of AV EA-Ab can be either the expression of a primary or an anamnestic response, but it is always a marker of a recent infection. These results agree with those previously reported for EA-Ab response to cytomegalovirus and varicella-zoster virus. In addition, the pattern of EA-Ab response in patients with nonprimary AV infections is similar to that observed in reactivated herpesvirus infections (3, 4) . Secondary AV infection and reactivation of a latent herpesvirus infection appear to be comparable events, both eliciting an anamnestic EA-Ab response.
In this study, infections by low-numbered AV serotypes were largely predominant, as reported in extended epidemiological studies (1). However, a fair number of infections by AV type 8 and high-numbered AV serotypes were also found in infants and young children. In addition, in two infants (one, case R-4, from a lower socioeconomic setting; the other, case 1141, with multiple congenital malformations and several admissions to different hospitals) infections by seven AV serotypes of four different groups were detected. It is well known that heterotypic neutralizing (12, 18) and HI (17, 18) Ab response may occur, mainly among serotypes of the same (11, 14, 15) ; intergroup cross-reactions have also been described (11, 15, 19 In most patients with acute AV infections, HI or neutralizing Ab or both are associated with EA-Ab in convalescent-phase sera. However, in infants less than 6 months old, as well as in older patients, the anamnestic EA-Ab response occasionally may not be associated with detectable HI or neutralizing Ab to any serotype of the corresponding AV group or both. This finding might be due to the well-known impairment of the AV Ab response frequently found in infants and young children (18) ; it could also depend on remote infections by AV types 32 to 35 (not tested in the present study) or by as yet unidentified serotypes, such as enteric adenoviruses (2) .
Although the EA-Ab titers observed in primary and secondary infections are not appreciably different, it is noteworthy that their level appears related to the AV group responsible for actual or remote infections. Thus, titers of 21:64 are often detected in response to group B, C, and E infections, whereas lower titers are usually found after group A or D infections. The only difference between primary and secondary EAAb response detected by IPA-IgG is the presence of a homotypic cytoplasmic staining, associated with nuclear staining, in convalescent-phase sera from patients with primary AV infections. This finding has been previously observed by using IFA, with sera from tumor-bearing hamsters (14) or antisera against a DNA-binding protein extracted from AV type 2-infected cells (20) . Thus, some AV-EA apparently react only with EA-Ab produced during the primary response.
In conclusion, our observations define the specificity of the EA-Ab response to different human AV groups in naturally occurring AV infections and we document for the first time the appearance of an anamnestic EA-Ab response in every secondary AV infection. In addition, these findings can be applied in diagnostic virology for the rapid diagnosis of a current (or recent) AV infection on a single serum sample and for rapid group identification of clinical isolates by IPA-IgG, with type-specific animal an-INFECT. IMMUN. tisera containing EA-Ab (one for each group) or sera from patients with primary AV infections.
